Cabaletta Bio
(NASDAQ) CABA
Cabaletta Bio Financials at a Glance
Market Cap
$329.52M
Revenue (TTM)
$0.00
Net Income (TTM)
$167.86M
EPS (TTM)
$-2.29
P/E Ratio
-1.29
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$2.96
Volume
87,000
Open
$2.66
Price
$2.96
Volume
87,000
Open
$2.66
Previous Close
$2.96
Daily Range
$2.66 - $2.98
52-Week Range
$0.99 - $3.78
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$2.96
Volume
87,000
Open
$2.66
Previous Close
$2.96
Daily Range
$2.66 - $2.98
52-Week Range
$0.99 - $3.78
CABA News
CABA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cabaletta Bio
Industry
Biotechnology
Sector
Health CareEmployees
156
CEO
Steven Nichtberger, MD
Website
www.cabalettabio.comHeadquarters
Philadelphia, PA 19104, US
CABA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-127%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-77.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$329.52M
Shares Outstanding
111.32M
Volume
87.00K
Short Interest
0.00%
Avg. Volume
3.04M
Financials (TTM)
Gross Profit
$1.65M
Operating Income
$172.24M
EBITDA
$170.59M
Operating Cash Flow
$131.08M
Capital Expenditure
$1.23M
Free Cash Flow
$132.31M
Cash & ST Invst.
$133.60M
Total Debt
$27.10M
Cabaletta Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.30M
+377.4%
Gross Margin
0.00%
N/A
Market Cap
$329.52M
N/A
Market Cap/Employee
$2.05M
N/A
Employees
161
N/A
Net Income
$41.92M
-28.6%
EBITDA
$49.05M
-56.4%
Quarterly Fundamentals
Net Cash
$106.50M
-28.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.88M
-48.8%
Short Term Debt
$24.22M
+142.8%
Return on Assets
-1.02%
N/A
Return on Invested Capital
-1.50%
N/A
Free Cash Flow
$35.55M
-51.3%
Operating Cash Flow
$35.34M
-52.9%